Mammography Quality Concerns Prompt FDA Intervention at North Jersey Imaging Facility
On May 21st, the US Food and Drug Administration (FDA) issued a “Safety Communication” regarding Advanced Women’s Imaging (AWI), located…
On May 21st, the US Food and Drug Administration (FDA) issued a “Safety Communication” regarding Advanced Women’s Imaging (AWI), located…
A bill currently moving through the New Jersey legislature aims to seriously limit physicians’ choices when it comes to the
The United States Food and Drug Administration announced on Monday that they have classified a voluntary recall of Edwards Lifesciences
Tris Pharma, Inc., a New Jersey based pharmaceutical manufacturer, has issued a voluntary recall of infant ibuprofen that may contain
An eleventh child died late last week as the result of an adenovirus outbreak at the Wanaque Center for Nursing
On September 24th, the US Food and Drug Administration (FDA) issued a “Safety Communication” regarding Aims Diagnostic Imaging, located in
On Tuesday, January 2, 2018, The United States Food & Drug Administration (FDA) issued a Class I recall of Johnson
In an opinion piece for Philly.com, Pennsylvania Treasurer, Joe Torsella, calls on the pharmaceutical industry to be held accountable for
The United States House of Representatives may vote this week on a bill (House Resolution 1215) that will do grave
An article in the March edition of the Journal of Patient Safety discussed medical error related deaths in the US,